Author

Destiny Aranovitch

QIMR Berghofer Medical Research Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alex William HewittiD· 1 shared Amali S. Fernando· 1 shared Anthony L. CookiD· 1 shared Anthony Robert WhiteiD· 1 shared Elina Casoli· 1 shared Eske M. DerksiD· 1 shared Juliana C.S. ChavesiD· 1 shared Lotta E. OikariiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Alex William HewittORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

NeurosciencebioRxivPreprintMay 15, 2026

Computational drug repurposing identifies N-acetylglucosamine as a potential therapeutic compound for CLN3 Batten disease

Elina Casoli, Amali S. Fernando, Juliana C.S. Chaves…·Lotta E. Oikari

The paper uses computational drug repurposing to identify N-acetylglucosamine as a potential therapy for CLN3 Batten disease, showing it reduces lipofuscin burden in cell models.

DOI 10.64898/2026.05.12.724723

humanbulk RNA-seq

𝕏 PostBluesky